Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus

This publication has 29 references indexed in Scilit:

• Alpha cell function in health and disease: influence of glucagon-like peptide-1
  Diabetologia, 2005
• Altered Homeostatic Adaptation of First- and Second-Phase β-Cell Secretion in the Offspring of Patients With Type 2 Diabetes
  Diabetes, 2003
• Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
  American Journal of Physiology-Endocrinology and Metabolism, 2002
• Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
  The Lancet, 2002
• GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1999
• Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
  Diabetes Care, 1998
• Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns
  Journal of Endocrinology, 1993
• Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
  The Journal of Clinical Endocrinology & Metabolism, 1993
• Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
  Journal of Clinical Investigation, 1977
• Abnormal Alpha-Cell Function in Diabetes
  New England Journal of Medicine, 1970